$15.33
-$0.03
(-0.20%)
Quote as of 10:42 AM EST on 02/15/12
Ligand Pharmaceuticals, Inc.
NASDAQ:LGND
|
$15.33
-$0.03
(-0.20%)
|
|
| Today's Open | $15.49 |
|---|---|
| Previous Close | $15.36 |
| Daily Range | $15.21 - $15.52 |
| 52-Week Range | $9.00 - $16.24 |
| Market Cap | $301.60M |
| P/E Ratio | 9.85 |
| Dividend (Yield) | $0.00 (0.0%) |
| Volume | 13,105 |
| Average Daily Volume | 85,710 |
| Current FY EPS | $0.05 |
LGND Information
| Description |
|---|
| Develops and markets new drugs that address critical unmet medical needs in the areas of cancer, mens and womens health, skin diseases, osteoporosis, and metabolic, cardiovascular and inflammatory diseases. |
| Sector |
| Healthcare |
| Industry |
| Biotechnology |
News & Commentary
Ligand Pharmaceuticals Crushes Estimates
Pfizer To Seek FDA Approval For Long-Stalled Menopause Drug
3 "Insider" Stocks to Watch this Earnings Season
Reshuffling Yahoo!'s Board: A New House of Cards?
3 Stocks Near 52-Week Highs Worth Selling
12 Biotech Stocks the Insiders Are Buying
Low-Priced Biotech Stocks With Insider Buying
6 Stocks With Substantial Insider Buying
Glaxo Gets EU Approval To Sell Blood Platelet Booster Revolade
